Abbott Entering Embolic Protection, Carotid Stent Markets Via MedNova

Abbott Labs is anticipating FDA approval of MedNova's CardioShield embolic filter device for saphenous vein graft applications in 2003, following a Feb. 2 announcement of an exclusive worldwide distribution agreement between the companies.